BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 629573)

  • 1. Effects of occlusive tape systems on the mitotic activity of epidermis. With and without corticosteroids.
    Fisher LB; Maibach HI; Trancik RJ
    Arch Dermatol; 1978 Mar; 114(3):384-6. PubMed ID: 629573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variably occlusive tape systems and the mitotic activity of stripped human epidermis. Effects with and without hydrocortisone.
    Fisher LB; Maibach HI; Trancik RJ
    Arch Dermatol; 1978 May; 114(5):727-9. PubMed ID: 646393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissue.
    Kristensen JK; Wadskov S; Henriksen O
    Acta Derm Venereol; 1978; 58(2):145-8. PubMed ID: 76394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency classification of topical corticosteroids: modern perspectives.
    Ashworth J
    Acta Derm Venereol Suppl (Stockh); 1989; 151():20-5; discussion 47-52. PubMed ID: 2696307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of corticosteroids on human epidermal mitotic activity.
    Fisher LB; Maibach HI
    Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flurandrenolone tape. A new preparation for occlusive therapy.
    Weiner MA
    J Invest Dermatol; 1966 Aug; 47(1):63-6. PubMed ID: 25622353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
    Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical application of potent glucocorticoids augments epidermal beta-adrenergic adenylate cyclase response in vivo.
    Kajita S; Iizuka H; Hirokawa M; Tsutsui M; Mizumoto T
    Acta Derm Venereol; 1986; 66(6):491-6. PubMed ID: 2433868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psoriasis bio-assay for topical corticosteroid activity.
    Dumas KJ; Scholtz JR
    Acta Derm Venereol; 1972; 52(1):43-8. PubMed ID: 4111105
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the assay of topical corticosteroids.
    Marks R; Pongsehirun D; Saylan T
    Br J Dermatol; 1973 Jan; 88(1):69-74. PubMed ID: 4686544
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of polythene occlusion and topical corticosteroids on resistance to friction injury in the skin.
    Comaish S
    Acta Derm Venereol; 1974; 54(1):53-4. PubMed ID: 4135167
    [No Abstract]   [Full Text] [Related]  

  • 14. Plethysmographic recordings of skin pulses. VI. Further measurements of the vasoconstriction produced by corticosteroids.
    Thune P
    Acta Derm Venereol; 1972; 52(4):303-7. PubMed ID: 4115885
    [No Abstract]   [Full Text] [Related]  

  • 15. Transmittance properties of flurandrenolide tape for psoriasis: helpful adjunct to phototherapy.
    Setaluri V ; Clark AR; Feldman SR
    J Cutan Med Surg; 2000 Oct; 4(4):196-8. PubMed ID: 11231197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
    Thalén A; Brattsand R; Andersson PH
    Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-induced atrophy in an animal and human model.
    Kirby JD; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():111-9. PubMed ID: 1268071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effectiveness of locally administered corticosteroids].
    Semrádová V; Horácek J
    Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.